Beck Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,714
| Closed | -$292K | – | 141 |
|
|
2022
Q1 | $292K | Hold |
4,714
| – | – | 0.09% | 144 |
|
|
2021
Q4 | $336K | Sell |
4,714
-65
| -1% | -$4.63K | 0.1% | 127 |
|
|
2021
Q3 | $358K | Hold |
4,779
| – | – | 0.12% | 124 |
|
|
2021
Q2 | $370K | Sell |
4,779
-56
| -1% | -$4.34K | 0.12% | 117 |
|
|
2021
Q1 | $357K | Hold |
4,835
| – | – | 0.13% | 100 |
|
|
2020
Q4 | $339K | Sell |
4,835
-175
| -3% | -$12.3K | 0.14% | 95 |
|
|
2020
Q3 | $284K | Sell |
5,010
-120
| -2% | -$6.8K | 0.16% | 64 |
|
|
2020
Q2 | $299K | Buy |
5,130
+504
| +11% | +$29.4K | 0.15% | 73 |
|
|
2020
Q1 | $215K | Sell |
4,626
-2,795
| -38% | -$130K | 0.2% | 59 |
|
|
2019
Q4 | $414K | Buy |
+7,421
| New | +$414K | 0.2% | 78 |
|